Skip to main content
    A

    Alignment Healthcare LLC (ALHC)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $7.47
    +0.11 (+1.49%)

    Market Cap: $1.54B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Alignment Healthcare LLC (ALHC) Financials: Revenue, Profit and Cash Flow

    Updated Jul 30, 2026. Financial statements from company filings, amounts in US dollars.

    Alignment Healthcare LLC reported revenue of $3.95B for the fiscal year ended Dec 31, 2025, up 46.1% from the year before. That year, net income was -$978.00K with a net margin of 0.0%, operating cash flow was $139.93M and free cash flow was $113.15M. The quarter ended Jun 30, 2026 had revenue of $1.34B and net income of $36.56M.

    Revenue and Margins

    The operating margin was 0.4% in the fiscal year ended Dec 2025, the highest of the 7 years shown. Over the 6 years to Dec 2025, revenue grew from $756.96M, a compound annual rate of 31.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$3.95B+46.1%100.0%0.4%0.0%
    Dec 2024$2.70B+48.3%100.0%-3.8%-4.7%
    Dec 2023$1.82B+27.2%100.0%-7.0%-8.1%
    Dec 2022$1.43B+22.8%100.0%-9.0%-10.4%
    Dec 2021$1.17B+21.7%100.0%-15.2%-16.7%
    Dec 2020$959.22M+26.7%100.0%-0.5%-2.4%
    Dec 2019$756.96MN/A100.0%-3.9%-5.9%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, net income rose 133.6% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$3.95B$2.70B$1.82B$1.43B$1.17B$959.22M$756.96M
    Gross profit$3.95B$2.70B$1.82B$1.43B$1.17B$959.22M$756.96M
    Operating income$14.75M-$101.56M-$127.82M-$128.64M-$178.07M-$5.26M-$29.48M
    Net income-$978.00K-$128.07M-$148.17M-$149.64M-$195.29M-$22.93M-$44.73M
    EBITDA$47.08M-$73.13M-$104.04M-$109.30M-$159.56M$11.66M-$11.30M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$1.34B$1.24B$1.01B$993.70M$1.02B$926.93M$701.24M$692.43M$681.29M$628.60M$465.39M$456.71M
    Gross profit$1.34B$1.24B$1.01B$993.70M$1.02B$926.93M$701.24M$692.43M$681.29M$628.60M$465.39M$456.71M
    Operating income$42.10M$15.50M-$10.28M$7.68M$22.75M-$5.39M-$22.55M-$19.52M-$18.38M-$41.11M-$41.91M-$29.76M
    Net income$36.56M$11.42M-$11.01M$3.73M$15.65M-$9.35M-$31.06M-$26.43M-$24.00M-$46.58M-$47.23M-$35.08M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $325.13M by $250.68M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$1.07B$782.06M$591.88M$633.86M$630.89M$338.50M$193.44M
    Current assets$951.58M$661.64M$483.54M$544.55M$552.86M$264.68M$127.35M
    Cash and equivalents$575.82M$432.86M$202.90M$409.55M$466.60M$207.31M$86.48M
    Total liabilities$886.51M$681.11M$433.81M$394.56M$324.84M$307.89M$272.15M
    Short-term debt$1.96M$1.21M$1.72M$4.20M$3.71M$3.35MN/A
    Long-term debt$323.18M$321.43M$161.81M$160.90M$150.62M$144.17M$137.96M
    Shareholder equity$179.28M$99.85M$156.95M$238.13M$306.04M$30.61M-$78.71M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$1.28B$1.26B$1.07B$1.10B$1.00B$895.62M$782.06M$692.29M$716.26M$633.23M$591.88M$770.79M
    Total liabilities$1.01B$1.05B$886.51M$940.74M$859.18M$786.62M$681.11M$576.66M$591.46M$501.21M$433.81M$581.19M
    Cash and equivalents$693.45M$705.58M$577.94M$618.07M$470.27M$446.18M$432.86M$340.30M$339.01M$238.90M$202.90M$391.64M
    Shareholder equity$265.13M$206.88M$179.28M$161.87M$140.97M$108.13M$99.85M$114.55M$123.70M$130.93M$156.95M$188.50M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 80.9% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$139.93M$34.77M-$59.19M-$45.43M-$78.78M$7.56M$9.21M
    Capital expenditures$26.78M$41.42M$35.99M$27.82M$18.36M$15.71M$10.24M
    Free cash flow$113.15M-$6.65M-$95.18M-$73.24M-$97.14M-$8.15M-$1.04M
    Dividends paidN/AN/AN/A$100.00K$0$0$0
    Share repurchasesN/AN/AN/AN/A$30.48M$4.88M$1.98M
    Investing cash flow-$14.97M$39.19M-$147.26M-$28.22M-$20.82M-$16.36M-$10.24M
    Financing cash flow$18.04M$156.03M$105.00K$16.59M$360.13M$130.12M$52.66M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$17.31M$128.68M-$50.38M$144.56M$29.13M$16.62M-$8.71M$26.19M$23.53M-$6.24M-$187.47M$5.99M
    Capital expenditures$10.14M$7.36M$5.03M$5.50M$8.00M$8.25M$9.28M$9.28M$11.73M$11.12M$10.60M$9.55M
    Free cash flow-$27.46M$121.32M-$55.40M$139.06M$21.13M$8.36M-$18.00M$16.91M$11.80M-$17.36M-$198.06M-$3.56M
    Last 12 quarters

    Frequently Asked Questions About ALHC

    What is Alignment Healthcare LLC's annual revenue?

    Alignment Healthcare LLC reported revenue of $3.95B for the fiscal year ended Dec 31, 2025.

    How fast is Alignment Healthcare LLC's revenue growing?

    Revenue was up 46.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 40.2%.

    Is Alignment Healthcare LLC profitable?

    No. Alignment Healthcare LLC reported net income of -$978.00K for the fiscal year ended Dec 31, 2025, with a net margin of 0.0%.

    How much free cash flow does ALHC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $139.93M minus capital expenditures of $26.78M produced free cash flow of $113.15M.

    How much debt does Alignment Healthcare LLC have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $323.18M, short-term debt of $1.96M and cash and equivalents of $575.82M.